Hot Features
Premium
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Zeitraum:
Zeichenmodus:
| Volumen | 1.324.672 |
|
|||||
| News | (2) |
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| SAB Biotherapeutics Inc | SABSW | NASDAQ | Equity Warrant |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,0033 | 31,43% | 0,0138 | 01:25:29 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 0,0105 | 0,0105 | 0,055 | 0,0168 | 0,0105 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen |
|---|---|---|---|---|
| 1.248 | 1.324.672 | 0,0345968 | 45.829 | - |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 01:25:27 | formt | 1.847 | 0,0138 | USD |
Finanzwerte SABSW
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 1,06M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News SAB Biotherapeutics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 07.7.2026 | 14:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07.7.2026 | 14:00 | GlobeNewswire Inc. | Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of.. |
| 18.6.2026 | 22:35 | Edgar (US Regulatory) | Form 8-K - Current report |
| 29.5.2026 | 14:00 | GlobeNewswire Inc. | SAB BIO to Present Data on SAB-142 at The American Diabetes.. |
| 15.5.2026 | 12:28 | Edgar (US Regulatory) | Form SCHEDULE 13G - Statement of Beneficial Ownership by.. |
| 12.5.2026 | 13:35 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 12.5.2026 | 13:30 | GlobeNewswire Inc. | SAB BIO Reports Q1 2026 Financial Results and Recent.. |
| 05.5.2026 | 14:30 | GlobeNewswire Inc. | SAB BIO to Host First Quarter 2026 Financial Results.. |
| 04.5.2026 | 22:35 | Edgar (US Regulatory) | Form 8-K - Current report |
| 30.4.2026 | 22:45 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 22.4.2026 | 14:13 | Edgar (US Regulatory) | Form 8-K - Current report |
| 22.4.2026 | 13:00 | GlobeNewswire Inc. | SAB BIO Presents Additional Clinical and Mechanistic Data.. |
Forum SAB Biotherapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
SABSW Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 6 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Jahr | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 5 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
NASDAQ:SABSW -
What is the current SAB Biotherapeutics Inc share price?
The current share price of SAB Biotherapeutics Inc is US$ 0,0138
What is the 1 year trading range for SAB Biotherapeutics Inc share price?
SAB Biotherapeutics Inc has traded in the range of US$ 0,00 to US$ 0,00 during the past year
